TRAWS PHARMA INC (TRAW)

US68232V8019 - Common Stock

5.02  -0.31 (-5.9%)

After market: 5.02 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
226K
8.26%
226K226K234.6K
3.81%
234.6K306K
30.43%
EBITDA
YoY % growth
-16.482M
36.13%
-19.613M
-19.00%
-20.282M
-3.41%
-23.97M
-18.18%
-29.172M
-21.70%
-33.864M
-16.08%
EBIT
YoY % growth
-16.496M
33.67%
-19.627M
-18.98%
-20.298M
-3.42%
-144.343M
-611.12%
-32.557M
77.44%
-33.864M
-4.01%
Operating Margin
-7,299.12%-8,684.51%-8,981.42%-61,527.39%-13,877.83%-11,066.67%
EPS
YoY % growth
-0.94
51.79%
-0.91
3.19%
-0.90
1.10%
-157.44
-17,393.00%
-36.23
76.99%
-0.83
97.72%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-7.14
-3,657.89%
-7.91
-3,269.57%
-8.42
-3,200.00%
-8.93
-1.31%
-9.18
-28.57%
Revenue
Q2Q % growth
61.2K
9.29%
61.2K
9.29%
61.2K
7.37%
61.2K
7.37%
61.2K
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
N/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-8.81
-3,730.43%
-6.25-2.56-41.02%
Q2 2024
Q2Q % growth

-27.50%
-0.26%
Q1 2024
Q2Q % growth

16.21%
-0.23%
Q4 2023
Q2Q % growth
-0.19
26.92%
-0.260.0726.47%
Q3 2023
Q2Q % growth
-0.23
11.54%
-0.300.0722.24%
Q2 2023
Q2Q % growth
-0.20
-5.26%
-0.320.1237.25%
Q1 2023
Q2Q % growth
-0.28
-40.00%
-0.300.027.73%
Q4 2022
Q2Q % growth
-0.26
-73.33%
-0.290.038.96%
Q3 2022
Q2Q % growth
-0.26
-18.18%
-0.22-0.04-19.95%
Q2 2022
Q2Q % growth
-0.19
29.63%
-0.200.015.68%
Q1 2022
Q2Q % growth
-0.20
33.33%
-0.19-0.01-3.20%
Q4 2021
Q2Q % growth
-0.15
66.67%
-0.280.1345.53%
Q3 2021
Q2Q % growth
-0.22
51.11%
-0.330.1133.97%
Q2 2021
Q2Q % growth
-0.27
55.00%
-0.290.027.12%
Q1 2021
Q2Q % growth
-0.30
33.33%
-0.460.1634.64%
Q4 2020
Q2Q % growth
-0.45
92.49%
-0.540.0915.97%
Q3 2020
Q2Q % growth
-0.45
96.00%
-0.510.0611.76%
Q2 2020
Q2Q % growth
-0.60
93.33%
-0.46-0.14-30.72%
Q1 2020
Q2Q % growth
-0.45
97.67%
-0.840.3946.52%
Q4 2019
Q2Q % growth
-5.99
70.84%
-3.77-2.22-58.79%
Q3 2019
Q2Q % growth
-11.25
20.21%
-9.33-1.92-20.54%
Q2 2019
Q2Q % growth
-9.00
42.86%
-12.583.5828.48%
Q1 2019
Q2Q % growth
-19.35
74.71%
-15.84-3.51-22.19%
Q4 2018
Q2Q % growth
-20.55 -13.31-7.24-54.38%
Q3 2018
Q2Q % growth
-14.10 -17.753.6520.55%
Q2 2018
Q2Q % growth
-15.75 -17.601.8510.49%
Q1 2018
Q2Q % growth
-76.50 -90.2713.7715.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
57K 59.16K-2.16K-3.65%
Q2 2024
Q2Q % growth
57K 61.2K-4.2K-6.86%
Q1 2024
Q2Q % growth
56K
-38.31%
61.2K-5.2K-8.50%
Q4 2023
Q2Q % growth
56K
-5.34%
66.637K-10.637K-15.96%
Q3 2023
Q2Q % growth
57K
-3.23%
70.635K-13.635K-19.30%
Q2 2023
Q2Q % growth
57K
-2.39%
70.635K-13.635K-19.30%
Q1 2023
Q2Q % growth

4.30%
90.78K%
Q4 2022
Q2Q % growth

-2.52%
59.16K%
Q3 2022
Q2Q % growth

8.29%
58.905K%
Q2 2022
Q2Q % growth

186.25%
58.395K%
Q1 2022
Q2Q % growth

42.22%
87.037K%
Q4 2021
Q2Q % growth

48.75%
60.69K%
Q3 2021
Q2Q % growth

-96.17%
54.397K%
Q2 2021
Q2Q % growth

-88.44%
20.4K%
Q1 2021
Q2Q % growth

-61.04%
61.2K%
Q4 2020
Q2Q % growth

-85.77%
40.8K%
Q3 2020
Q2Q % growth

73.47%
1.422M%
Q2 2020
Q2Q % growth

-65.03%
176.46K%
Q1 2020
Q2Q % growth

81.18%
157.08K%
Q4 2019
Q2Q % growth

56.40%
286.62K%
Q3 2019
Q2Q % growth

20.31%
819.743K%
Q2 2019
Q2Q % growth

128.34%
504.645K%
Q1 2019
Q2Q % growth

-57.50%
86.7K%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-2313.79% -2313.79% -2.46% -2461.4%
Revenue0% 0% 0.88% 0.88%